Anaemia in chronic heart failure: Is there a rationale to treat?

Hellenic Journal of Cardiology

Volumn 48, Issue 4, 2007, Pages 249-250

  Kremastinos, Dimitrios T ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; INTERLEUKIN 6; IRON; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CONFERENCE PAPER; EUROPE; HEART FAILURE; IRON DEFICIENCY; KIDNEY DISEASE; MORBIDITY; ARTICLE; BLOOD; CHRONIC DISEASE; CONGESTIVE HEART FAILURE; HUMAN; PHYSIOLOGY;

ANEMIA; CHRONIC DISEASE; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY DISEASES;

EID: 34848889666     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Okonko DO, Anker SD: Anemia in chronic heart failure: pathogenetic mechanisms. J Card Fail 2004; 10: S5-S9.
2. Van der Meer P, Voors AA, Lipsic E, et al: Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. J Am Coll Cardiol 2004; 44: 63-67.
3. Silverberg DS, Wexler D, Iaina A: The importance of anemia and its correction in the management of severe congestive heart failure. Eur J Heart Fail 2002; 4: 681-686.
4. Kremastinos DT, Tsetsos GA, Tsiapras DP, Karavolias GK, Ladis VA, Kattamis CA: Heart failure in beta thalassemia: a 5-year follow-up study. Am J Med 2001; 111: 349-354.
5. Engle MA, Erlandson M, Smith CH: Late cardiac complications of chronic, severe refractory anemia with hemochromatosis. Circulation 1964; 30: 698-705.
6. Silverberg DS, Wexler D, Sheps D, et al: The effect of correction of mild anemia in severe, resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 2001; 37: 1775-1780.
7. Mancini D, Katz S, Lang C, LaManca J, Hudaihed A, Androne A: Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003; 107: 294-299.
8. Ponikowski P, Anker SD, Szachniewicz J, et al: Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 2007; 49: 753-762.
9. Kourea K, Parissis J, Farmakis D, et al: Effects of recombinant human erythropoietin on left ventricular diastolic and systolic function, and plasma biomarkers of neurohormonal activation in patients with chronic heart failure and anemia. Circulation 2006 (Suppl. I): C122.
10. Feng Q: Beyond erythropoiesis: the anti-inflammatory effects of erythropoietin. Cardiovasc Res 2006; 71: 615-617.